Clonal Heterogeneity of Acute Myeloid Leukemia Treated with the IDH2 inhibitor Enasidenib

Vyas P., Quek L., David M., Kennedy A., Metzner M., Amatangelo M., Shih A., Stoilova B., Quivoron C., Heiblig M., Willekens C., Saada V., Alsafadi S., Vijayabaskar M., Peniket A., Bernard O., Agresta S., Yen K., MacBeth K., Stein E., Vassiliou G., Levine R., De Botton S., Thakurta A., Penard-Lacronique V.

Type

Journal article

Publisher

Nature Publishing Group

Publication Date

2018-07-16T00:00:00+00:00

Permalink Close